Table 1.
Average | Range | ||
Age (years) | 52.4 | 16-85 | |
n | % | ||
Gender | |||
Male | 74 | 55.6 | |
Female | 59 | 44.4 | |
Stage | |||
I-II | 61 | 45.9 | |
III-IV | 72 | 54.1 | |
Presence of bulky disease* | 33 | 24.8 | |
Presence of B symptoms** | 82 | 61.7 | |
International Prognostic Index | |||
0-2 | 83 | 63.4 | |
3-5 | 48 | 36.7 | |
Bone marrow involvement | 13 | 10.0 | |
Increased lactic dehydrogenase (U/L) | 98 | 74.8 | |
Number of extranodal sites involved | |||
0-1 | 123 | 92.5 | |
≥ 2 | 10 | 7.5 | |
Prophylactic intrathecal chemotherapy | |||
Yes | 9 | 7.1 | |
No | 118 | 92.9 | |
Response to treatment | |||
Complete | 75 | 59.5 | |
Partial | 18 | 14.3 | |
Refractory | 33 | 26.2 |
Bulky: mass size > 10 cm;
B symptoms: night fever, night sweats and fever